Company / Capital Expenditures
Zai Lab Ltd Capital Expenditures History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$8.1M
FY2025
5-year range
$5.7M / $10.1M
FY2021-FY2025
Trend
+43.2%
vs FY2024
Sector context
#64 of 194
Health Care
What the data says
At $8M, Zai Lab Ltd's capital expenditures ranks #64 of 194 in the Health Care sector. Capital Expenditures returned to growth in FY2025 after 2 years of decline, reaching $8M.
Based on SEC 10-K filings.
$8M in FY2025 with a 5-year CAGR of -4.2%.
Improved from $7M to $8M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -7.2%
- 5-Year CAGR
- -4.2%
- 10-Year CAGR
- -
Sector benchmark
#64 of 194 in Health CareTop 33% of 194This company $8.1M Sector average $117.5M
▼
-93.1% below sector average
Key checks
Key Insights
- 5-year CAGR of -4.2%, indicating a declining trend.
- In FY2025, capital expenditures increased 43.2% year-over-year.
- Ranks #64 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.09 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.1M | +43.2% |
| FY2024 | $5.7M | -21.6% |
| FY2023 | $7.2M | -28.8% |
| FY2022 | $10.1M | +67.9% |
| FY2021 | $6.0M | -39.7% |
| FY2020 | $10.0M | +65.9% |
| FY2019 | $6.0M | -39.7% |
| FY2018 | $10.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026